The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 24
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte ROBERT E. GARFIELD and KRISTOF CHWALISZ
__________
Appeal No. 2001-0982
Application No. 08/310,950
__________
ON BRIEF
__________
Before SCHEINER, ADAMS and GREEN, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 1-23, which are all the claims pending in the
application.
Claims 1 and 16 are illustrative of the subject matter on appeal and are
reproduced below:
1. A method of treatment selected from the group consisting of (a)
preventing or treating atherosclerotic vascular disease in a mammal;
b) hormone replacement therapy in a peri- or post-menopausal
female mammal; and c) treating hypertension in a mammal, which
comprises administering to the afflicted mammal an amount of
prostacyclin or prostacyclin analog in combination with one or more
of an estrogen and a progestin, in amounts effective to ameliorate or
prevent the appearance of the symptoms thereof, wherein said
amounts are synergistically effective and the amounts of
prostacyclin, prostacyclin analog, estrogen or progesterone are
individually ineffective or marginally effective.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007